English
NOVARTIS AG
EDGAR615 filing records in this dataset, filed from 2002-11-29 to 2026-09-08. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 11.4 billion USD Source
Exact value
11435000000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- Not available
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-09-08.
Financial data available through: 2025-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 11 of 11 periods available· newest 2025-12-31
- Net income: 11 of 11 periods available· newest 2025-12-31
- Operating cash flow: 11 of 11 periods available· newest 2025-12-31
- Capital expenditure: 11 of 11 periods available· newest 2025-12-31
- Total assets: 10 of 11 periods available· newest 2025-12-31
- Total liabilities: 10 of 11 periods available· newest 2025-12-31
- Current assets: 10 of 11 periods available· newest 2025-12-31
- Current liabilities: 10 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
- long term debt: No compatible figures in this window
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
+17.1%Prior period
USD 11.94 billion
–
Current period
USD 13.98 billion
–
Exact inputs and evidence
13984000000 − 11941000000 = 2043000000 USD
11941000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source13984000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+8.7%Prior period
USD 17.62 billion
–
Current period
USD 19.14 billion
–
Exact inputs and evidence
19144000000 − 17619000000 = 1525000000 USD
17619000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source19144000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+13.3%Prior period
USD 1.37 billion
–
Current period
USD 1.55 billion
–
Exact inputs and evidence
1548000000 − 1366000000 = 182000000 USD
1366000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source1548000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | USD 6.71 billion Exact valueExact value: 6712000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 11.48 billion Exact valueExact value: 11475000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.86 billion Exact valueExact value: 1862000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 9.61 billion Calculation and evidence11475000000 − 1862000000 USD Exact free cash flow: 9613000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2017 2017-01-01 – 2017-12-31 | USD 7.7 billion Exact valueExact value: 7703000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 12.62 billion Exact valueExact value: 12621000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.33 billion Exact valueExact value: 1325000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 11.3 billion Calculation and evidence12621000000 − 1325000000 USD Exact free cash flow: 11296000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2018-01-01 – 2018-12-31 | USD 12.61 billion Exact valueExact value: 12611000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 14.27 billion Exact valueExact value: 14272000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.25 billion Exact valueExact value: 1254000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 13.02 billion Calculation and evidence14272000000 − 1254000000 USD Exact free cash flow: 13018000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2019-01-01 – 2019-12-31 | USD 11.73 billion Exact valueExact value: 11732000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 13.63 billion Exact valueExact value: 13625000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.38 billion Exact valueExact value: 1379000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 12.25 billion Calculation and evidence13625000000 − 1379000000 USD Exact free cash flow: 12246000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | USD 8.07 billion Exact valueExact value: 8072000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 13.65 billion Exact valueExact value: 13650000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.28 billion Exact valueExact value: 1275000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 12.38 billion Calculation and evidence13650000000 − 1275000000 USD Exact free cash flow: 12375000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | USD 24.02 billion Exact valueExact value: 24021000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 15.07 billion Exact valueExact value: 15071000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.07 billion Exact valueExact value: 1066000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 14.01 billion Calculation and evidence15071000000 − 1066000000 USD Exact free cash flow: 14005000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | USD 6.96 billion Exact valueExact value: 6955000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 14.24 billion Exact valueExact value: 14236000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 916 million Exact valueExact value: 916000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 13.32 billion Calculation and evidence14236000000 − 916000000 USD Exact free cash flow: 13320000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | USD 14.85 billion Exact valueExact value: 14850000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 14.46 billion Exact valueExact value: 14458000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.06 billion Exact valueExact value: 1060000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 13.4 billion Calculation and evidence14458000000 − 1060000000 USD Exact free cash flow: 13398000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | USD 11.94 billion Exact valueExact value: 11941000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 17.62 billion Exact valueExact value: 17619000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.37 billion Exact valueExact value: 1366000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 16.25 billion Calculation and evidence17619000000 − 1366000000 USD Exact free cash flow: 16253000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | USD 13.98 billion Exact valueExact value: 13984000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 19.14 billion Exact valueExact value: 19144000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.55 billion Exact valueExact value: 1548000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 17.6 billion Calculation and evidence19144000000 − 1548000000 USD Exact free cash flow: 17596000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
615 filings · 1,297 latest values · 1,297 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001114448, 1114448, NVS, NVSEF, edgar:1114448
Also known as NOVARTIS AG, Novartis AG